Sofinnova Partners
Venture capitalParis · Pre-Seed–Late Stage
Investment thesis
Sofinnova Partners believes that backing life sciences companies which develop products to treat patients and address patient needs generates both meaningful clinical impact and attractive financial returns. The firm operates a comprehensive multi-fund platform with specialized teams investing across the therapeutic development lifecycle, from early-stage biopharma and medtech innovators through growth-stage companies preparing for commercialization, complemented by accelerator programs and industrial biotech strategies focused on sustainable solutions.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 4 of 149 portfolio companiesBiotech ×4Medical Devices ×3AgTech ×1AI & Machine Learning ×1Digital Health ×1
Investments · showing 60 of 149
founders shown can be your intro pathBioCorteX develops personalized therapeutics using a microbiome knowledge graph and proprietary biology emulation platform to tailor drug treatments for diverse populations. The company aims to improve treatment efficacy across different communities by accounting for individual microbiome variations in drug development.
AI & Machine LearningBiotechDigital HealthMedical Devices
<UNKNOWN>(CTO & Co-Founder)
Frequently asked questions
- What stage does Sofinnova Partners invest at?
- Sofinnova Partners invests at the Pre-Seed, Seed, Series A, Growth, Late Stage stages.
- What sectors does Sofinnova Partners focus on?
- Sofinnova Partners focuses on AgTech, Biotech, Digital Health, Medical Devices, New Materials.
- Where is Sofinnova Partners located?
- Sofinnova Partners is headquartered in Paris.
- Does Sofinnova Partners lead rounds?
- Yes, Sofinnova Partners leads investment rounds.
Images
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.
Novo Holdings is a holding and investment company managing the assets of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. The firm invests in life science companies across all development stages and manages a diversified portfolio including equities, bonds, real estate, infrastructure, and private equity.